Esophageal Cancer Practice Guidelines 2017 Edited by the Japan Esophageal Society: Part 1

Overview

Journal Esophagus

Publisher Springer

Specialties Gastroenterology
Oncology

Date 2018 Sep 2

PMID 30171413

Citations 211

Authors

Yuko Kitagawa

Takashi Uno

Tsuneo Oyama

Ken Kato

Hiroyuki Kato

Hirofumi Kawakubo

Osamu Kawamura

Motoyasu Kusano

Hiroyuki Kuwano

Hiroya Takeuchi

Yasushi Toh

Yuichiro Doki

Yoshio Naomoto

Kenji Nemoto

Eisuke Booka

Hisahiro Matsubara

Tatsuya Miyazaki

Manabu Muto

Akio Yanagisawa

Masahiro Yoshida

Affiliations

Soon will be listed here.

Citing Articles

Is There Bias in the Assessment of Contraindications for Resection? Disparities in the Surgical Management of Early-Stage Esophageal Cancer.

Boutros C, Drapalik L, Alvarado C, Bassiri A, Sinopoli J, Tapias Vargas L Diseases. 2025; 13(2).

PMID: 39997044 PMC: 11854519. DOI: 10.3390/diseases13020037.

Atezolizumab following definitive chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell carcinoma - a multicenter phase 2 trial (EPOC1802).

Bando H, Kumagai S, Kotani D, Mishima S, Irie T, Itahashi K Nat Cancer. 2025; .

PMID: 39972105 DOI: 10.1038/s43018-025-00918-1.

Nodal Downstaging of Esophageal Cancer After Neoadjuvant Therapy: A Cohort Study and Meta-Analysis.

Su F, Huang X, Yin J, Tang H, Tan L, Shen Y Cancer Med. 2025; 14(3):e70664.

PMID: 39918200 PMC: 11803740. DOI: 10.1002/cam4.70664.

Low skeletal muscle mass contributes to the prognosis of patients with superficial esophageal cancer treated with definitive chemoradiotherapy.

Nakagawa K, Hayashi Y, Adachi Y, Tajiri A, Fukuda H, Kimura E Esophagus. 2025; .

PMID: 39883331 DOI: 10.1007/s10388-025-01109-8.

Kangfuxin solution alleviates esophageal stenosis after endoscopic submucosal dissection: A natural ingredient strategy.

Zhou X, Ma D, He Y, Jin J, Wang H, Wang Y World J Gastroenterol. 2025; 31(1):98561.

PMID: 39777242 PMC: 11684190. DOI: 10.3748/wjg.v31.i1.98561.

References

Ishiguro S, Sasazuki S, Inoue M, Kurahashi N, Iwasaki M, Tsugane S . Effect of alcohol consumption, cigarette smoking and flushing response on esophageal cancer risk: a population-based cohort study (JPHC study). Cancer Lett. 2008; 275(2):240-6. DOI: 10.1016/j.canlet.2008.10.020. View

Chan R, Morrill S, Freeman Jr D, Colman M, Zwischenberger J . Bi-modality (chemo-radiation) versus tri-modality (chemo-radiation followed by surgery) treatment for carcinoma of the esophagus. Dis Esophagus. 2002; 14(3-4):202-7. DOI: 10.1046/j.1442-2050.2001.00185.x. View

Matsuda S, Tsubosa Y, Niihara M, Sato H, Takebayashi K, Kawamorita K . Comparison of transthoracic esophagectomy with definitive chemoradiotherapy as initial treatment for patients with esophageal squamous cell carcinoma who could tolerate transthoracic esophagectomy. Ann Surg Oncol. 2015; 22(6):1866-73. DOI: 10.1245/s10434-014-4337-7. View

Lorenzen S, Schuster T, Porschen R, Al-Batran S, Hofheinz R, Thuss-Patience P . Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie. Ann Oncol. 2009; 20(10):1667-73. DOI: 10.1093/annonc/mdp069. View

Ikeda K, Ishida K, Sato N, Koeda K, Aoki K, Kimura Y . Chemoradiotherapy followed by surgery for thoracic esophageal cancer potentially or actually involving adjacent organs. Dis Esophagus. 2002; 14(3-4):197-201. DOI: 10.1046/j.1442-2050.2001.00184.x. View

Yousef F, Cardwell C, Cantwell M, Galway K, Johnston B, Murray L . The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis. Am J Epidemiol. 2008; 168(3):237-49. DOI: 10.1093/aje/kwn121. View

De Manzoni G, Pedrazzani C, Pasini F, Bernini M, Minicozzi A, Giacopuzzi S . Chemoradiotherapy followed by surgery for squamous cell carcinoma of the thoracic esophagus with clinical evidence of adjacent organ invasion. J Surg Oncol. 2007; 95(3):261-6. DOI: 10.1002/jso.20640. View

Wong R, Malthaner R, Zuraw L, Rumble R . Combined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus: a practice guideline. Int J Radiat Oncol Biol Phys. 2003; 55(4):930-42. DOI: 10.1016/s0360-3016(02)04278-5. View

Nygaard K, Hagen S, Hansen H, Hatlevoll R, Hultborn R, Jakobsen A . Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg. 1992; 16(6):1104-9; discussion 1110. DOI: 10.1007/BF02067069. View

10.

Bergquist H, Wenger U, Johnsson E, Nyman J, Ejnell H, Hammerlid E . Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial. Dis Esophagus. 2005; 18(3):131-9. DOI: 10.1111/j.1442-2050.2005.00467.x. View

11.

Sur R, Levin C, Donde B, Sharma V, Miszczyk L, Nag S . Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma--an International Atomic Energy Agency study. Int J Radiat Oncol Biol Phys. 2002; 53(1):127-33. DOI: 10.1016/s0360-3016(02)02702-5. View

12.

Ohtsu A, Boku N, Muro K, Chin K, Muto M, Yoshida S . Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol. 1999; 17(9):2915-21. DOI: 10.1200/JCO.1999.17.9.2915. View

13.

Hironaka S, Ohtsu A, Boku N, Muto M, Nagashima F, Saito H . Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys. 2003; 57(2):425-33. DOI: 10.1016/s0360-3016(03)00585-6. View

14.

Adams R, Morgan M, Mukherjee S, Brewster A, Maughan T, Morrey D . A prospective comparison of multidisciplinary treatment of oesophageal cancer with curative intent in a UK cancer network. Eur J Surg Oncol. 2006; 33(3):307-13. DOI: 10.1016/j.ejso.2006.10.026. View

15.

Shinoda M, Ando N, Kato K, Ishikura S, Kato H, Tsubosa Y . Randomized study of low-dose versus standard-dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303). Cancer Sci. 2015; 106(4):407-12. PMC: 4409884. DOI: 10.1111/cas.12622. View

16.

Bedenne L, Michel P, Bouche O, Milan C, Mariette C, Conroy T . Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007; 25(10):1160-8. DOI: 10.1200/JCO.2005.04.7118. View

17.

Natsugoe S, Okumura H, Matsumoto M, Uchikado Y, Setoyama T, Yokomakura N . Randomized controlled study on preoperative chemoradiotherapy followed by surgery versus surgery alone for esophageal squamous cell cancer in a single institution. Dis Esophagus. 2006; 19(6):468-72. DOI: 10.1111/j.1442-2050.2006.00615.x. View

18.

Yamaguchi N, Isomoto H, Nakayama T, Hayashi T, Nishiyama H, Ohnita K . Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. Gastrointest Endosc. 2011; 73(6):1115-21. DOI: 10.1016/j.gie.2011.02.005. View

19.

Kawashima M, Kagami Y, Toita T, Uno T, Sugiyama M, Tamura Y . Prospective trial of radiotherapy for patients 80 years of age or older with squamous cell carcinoma of the thoracic esophagus. Int J Radiat Oncol Biol Phys. 2005; 64(4):1112-21. DOI: 10.1016/j.ijrobp.2005.09.027. View

20.

Freedman N, Park Y, Subar A, Hollenbeck A, Leitzmann M, Schatzkin A . Fruit and vegetable intake and esophageal cancer in a large prospective cohort study. Int J Cancer. 2007; 121(12):2753-60. DOI: 10.1002/ijc.22993. View